• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C反应蛋白单体形式与酶修饰低密度脂蛋白的结合:磷酸乙醇胺的作用

Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.

作者信息

Singh Sanjay K, Suresh Madathilparambil V, Hammond David J, Rusiñol Antonio E, Potempa Lawrence A, Agrawal Alok

机构信息

Department of Pharmacology, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, United States.

出版信息

Clin Chim Acta. 2009 Aug;406(1-2):151-5. doi: 10.1016/j.cca.2009.06.018. Epub 2009 Jun 21.

DOI:10.1016/j.cca.2009.06.018
PMID:19545552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2739981/
Abstract

BACKGROUND

The 5 subunits of native pentameric C-reactive protein (CRP) are dissociated to generate the monomeric form of CRP (mCRP) in some in vitro conditions, both physiological and non-physiological, and also in vivo. Many bioactivities of mCRP generated by urea-treatment of CRP and of mCRP generated by mutating the primary structure of CRP have been reported. The bioactivities of mCRP generated by spontaneous dissociation of CRP are largely unexplored.

METHODS

We purified mCRP generated by spontaneous dissociation of CRP and investigated the binding of mCRP to enzymatically-modified low-density lipoprotein (E-LDL).

RESULTS

mCRP was approximately 60 times more potent than CRP in binding to E-LDL. In the presence of the small-molecule compound phosphoethanolamine (PEt), at 37 degrees C, the binding of mCRP to E-LDL was enhanced <2-fold, while the binding of CRP to E-LDL was enhanced >10-fold. In contrast, PEt inhibited the binding of both CRP and mCRP to pneumococcal C-polysaccharide, another phosphocholine-containing ligand to which CRP and mCRP were found to bind. We have not investigated yet whether PEt alters the structure of CRP at 37 degrees C.

CONCLUSIONS

Combined data suggest that the targeting of CRP with the aim to monomerize CRP in vivo may be an effective approach to capture modified forms of LDL.

摘要

背景

在一些生理和非生理的体外条件下以及体内,天然五聚体C反应蛋白(CRP)的5个亚基会解离,生成单体形式的CRP(mCRP)。由尿素处理CRP产生的mCRP以及通过改变CRP一级结构产生的mCRP的许多生物活性已见报道。由CRP自发解离产生的mCRP的生物活性在很大程度上尚未被探索。

方法

我们纯化了由CRP自发解离产生的mCRP,并研究了mCRP与酶修饰的低密度脂蛋白(E-LDL)的结合。

结果

mCRP与E-LDL结合的效力约为CRP的60倍。在小分子化合物磷酸乙醇胺(PEt)存在的情况下,在37℃时,mCRP与E-LDL的结合增强不到2倍,而CRP与E-LDL的结合增强超过10倍。相反,PEt抑制了CRP和mCRP与肺炎球菌C多糖的结合,CRP和mCRP都被发现能与肺炎球菌C多糖结合,肺炎球菌C多糖是另一种含磷酸胆碱的配体。我们尚未研究PEt在37℃时是否会改变CRP的结构。

结论

综合数据表明,旨在使体内CRP单体化的靶向CRP方法可能是捕获修饰形式LDL的有效途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f4/2739981/0306cdfe936e/nihms125856f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f4/2739981/a4ad08aaea3f/nihms125856f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f4/2739981/42f0571525b2/nihms125856f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f4/2739981/1021d1ea409a/nihms125856f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f4/2739981/0306cdfe936e/nihms125856f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f4/2739981/a4ad08aaea3f/nihms125856f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f4/2739981/42f0571525b2/nihms125856f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f4/2739981/1021d1ea409a/nihms125856f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f4/2739981/0306cdfe936e/nihms125856f4.jpg

相似文献

1
Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.C反应蛋白单体形式与酶修饰低密度脂蛋白的结合:磷酸乙醇胺的作用
Clin Chim Acta. 2009 Aug;406(1-2):151-5. doi: 10.1016/j.cca.2009.06.018. Epub 2009 Jun 21.
2
Monomeric C-Reactive Protein in Serum With Markedly Elevated CRP Levels Shares Common Calcium-Dependent Ligand Binding Properties With an Dissociated Form of C-Reactive Protein.血清单体 C 反应蛋白在 CRP 水平显著升高时具有与 C 反应蛋白分离形式相同的钙依赖性配体结合特性。
Front Immunol. 2020 Feb 4;11:115. doi: 10.3389/fimmu.2020.00115. eCollection 2020.
3
Functionality of C-Reactive Protein for Atheroprotection.C-反应蛋白的抗动脉粥样硬化功能。
Front Immunol. 2019 Jul 16;10:1655. doi: 10.3389/fimmu.2019.01655. eCollection 2019.
4
C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells.与C反应蛋白结合的酶促修饰低密度脂蛋白不会将巨噬细胞转化为泡沫细胞。
J Immunol. 2008 Mar 15;180(6):4316-22. doi: 10.4049/jimmunol.180.6.4316.
5
Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.修饰型C反应蛋白对补体激活的影响:修饰型或单体型C反应蛋白在动脉粥样硬化病变中可能的补体调节作用。
Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):935-41. doi: 10.1161/01.ATV.0000206211.21895.73. Epub 2006 Feb 2.
6
Native and modified C-reactive protein bind different receptors on human neutrophils.天然和修饰的C反应蛋白与人中性粒细胞上的不同受体结合。
Int J Biochem Cell Biol. 2005 Feb;37(2):320-35. doi: 10.1016/j.biocel.2004.07.002.
7
Conversion of native oligomeric to a modified monomeric form of human C-reactive protein.人C反应蛋白从天然寡聚体形式向修饰单体形式的转变。
Int J Biochem Cell Biol. 1998 Dec;30(12):1415-26. doi: 10.1016/s1357-2725(98)00078-8.
8
Phosphoethanolamine-complexed C-reactive protein: a pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum.磷酸乙醇胺复合C反应蛋白:一种能与人血清中天然低密度脂蛋白结合的类药物大分子。
Clin Chim Acta. 2008 Aug;394(1-2):94-8. doi: 10.1016/j.cca.2008.04.015. Epub 2008 Apr 27.
9
Monomeric C-reactive protein decreases acetylated LDL uptake in human endothelial cells.单体C反应蛋白降低人内皮细胞中乙酰化低密度脂蛋白的摄取。
Clin Chem. 2009 Sep;55(9):1728-31. doi: 10.1373/clinchem.2009.125732. Epub 2009 Jul 17.
10
Current Position on the Role of Monomeric C-reactive Protein in Vascular Pathology and Atherothrombosis.单体 C 反应蛋白在血管病理学和动脉血栓形成中的作用的当前立场。
Curr Pharm Des. 2020;26(1):37-43. doi: 10.2174/1381612825666191216144055.

引用本文的文献

1
Structurally Altered, Not Wild-Type, Pentameric C-Reactive Protein Inhibits Formation of Amyloid-β Fibrils.结构改变而非野生型五聚体 C 反应蛋白抑制淀粉样β纤维的形成。
J Immunol. 2022 Sep 15;209(6):1180-1188. doi: 10.4049/jimmunol.2200148. Epub 2022 Aug 17.
2
C-Reactive Protein: Friend or Foe? Phylogeny From Heavy Metals to Modified Lipoproteins and SARS-CoV-2.C反应蛋白:敌还是友?从重金属到修饰脂蛋白及新型冠状病毒2的系统发生
Front Cardiovasc Med. 2022 Mar 24;9:797116. doi: 10.3389/fcvm.2022.797116. eCollection 2022.
3
Direct visualization of electrophoretic mobility shift assays using nanoparticle-aptamer conjugates.

本文引用的文献

1
Therapeutic potential of phosphoethanolamine-bound C-reactive protein in atherosclerosis.磷酸乙醇胺结合型C反应蛋白在动脉粥样硬化中的治疗潜力
Future Lipidol. 2008 Dec;3(6). doi: 10.2217/17460875.3.6.599.
2
C-reactive protein at the interface between innate immunity and inflammation.C-反应蛋白在先天免疫和炎症之间的界面。
Expert Rev Clin Immunol. 2008 May;4(3):379-90. doi: 10.1586/1744666X.4.3.379.
3
Crystal structures of Limulus SAP-like pentraxin reveal two molecular aggregations.鲎类 SAP 样五聚体蛋白的晶体结构揭示了两种分子聚集体。
使用纳米颗粒-适体偶联物直接可视化电泳迁移率变动分析。
Electrophoresis. 2012 Jan;33(2):348-51. doi: 10.1002/elps.201100308. Epub 2011 Dec 14.
4
C-reactive protein (CRP) aptamer binds to monomeric but not pentameric form of CRP.C-反应蛋白(CRP)适体与 CRP 的单体但不是五聚体结合。
Anal Bioanal Chem. 2011 Sep;401(4):1309-18. doi: 10.1007/s00216-011-5174-1. Epub 2011 Jul 2.
5
Identification of acidic pH-dependent ligands of pentameric C-reactive protein.鉴定五聚体 C 反应蛋白的酸性 pH 依赖性配体。
J Biol Chem. 2010 Nov 12;285(46):36235-44. doi: 10.1074/jbc.M110.142026. Epub 2010 Sep 14.
6
The binding of C-reactive protein, in the presence of phosphoethanolamine, to low-density lipoproteins is due to phosphoethanolamine-generated acidic pH.在磷酸乙醇胺存在的情况下,C反应蛋白与低密度脂蛋白的结合是由于磷酸乙醇胺产生的酸性pH值所致。
Clin Chim Acta. 2009 Nov;409(1-2):143-4. doi: 10.1016/j.cca.2009.08.013. Epub 2009 Aug 28.
7
Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis.通过定点诱变探究人C反应蛋白的磷酸胆碱结合位点。
J Biol Chem. 1992 Dec 15;267(35):25353-8.
J Mol Biol. 2009 Mar 13;386(5):1240-54. doi: 10.1016/j.jmb.2009.01.008.
4
Membrane activity of a C-reactive protein.
FEBS Lett. 2009 Mar 18;583(6):1001-5. doi: 10.1016/j.febslet.2009.02.019. Epub 2009 Feb 21.
5
Regulation of cell function by isoforms of C-reactive protein: a comparative analysis.C反应蛋白异构体对细胞功能的调节:一项比较分析。
Acta Biochim Pol. 2009;56(1):17-31. Epub 2009 Feb 13.
6
Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro.改性 C 反应蛋白由中风新生血管表达,是体外血管生成的有效激活剂。
Brain Pathol. 2010 Jan;20(1):151-65. doi: 10.1111/j.1750-3639.2008.00256.x. Epub 2009 Jan 19.
7
Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains.单体C反应蛋白通过与脂筏微区相互作用激活内皮细胞。
FASEB J. 2009 Jun;23(6):1806-16. doi: 10.1096/fj.08-116962. Epub 2009 Jan 9.
8
Reduced serum levels of autoantibodies against monomeric C-reactive protein (CRP) in patients with acute coronary syndrome.急性冠状动脉综合征患者中抗单体C反应蛋白(CRP)自身抗体的血清水平降低。
Clin Chim Acta. 2009 Feb;400(1-2):128-31. doi: 10.1016/j.cca.2008.10.002. Epub 2008 Oct 17.
9
Complement factor H binds to denatured rather than to native pentameric C-reactive protein.补体因子H与变性的而非天然的五聚体C反应蛋白结合。
J Biol Chem. 2008 Nov 7;283(45):30451-60. doi: 10.1074/jbc.M803648200. Epub 2008 Sep 11.
10
Phosphoethanolamine-complexed C-reactive protein: a pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum.磷酸乙醇胺复合C反应蛋白:一种能与人血清中天然低密度脂蛋白结合的类药物大分子。
Clin Chim Acta. 2008 Aug;394(1-2):94-8. doi: 10.1016/j.cca.2008.04.015. Epub 2008 Apr 27.